Portside Wealth Group’s Rentokil RTO Stock Holding History

Portside Wealth Group’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,619	Closed	-$245K	–	391
2023 Q3	$245K	Buy	6,619 +375	+6%	+$14.3K	0.05%	281
2023 Q2	$244K	Buy	+6,244	New	+$245K	0.05%	290

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

Portside Wealth Group's RTO Position: Q4 2023 in Review

Portside Wealth Group sold out of Rentokil (RTO) in Q4 2023, closing a stake of 6,619 shares — an estimated $245K sold.

Portside Wealth Group first reported a position in RTO in Q2 2023 and held it in 2 quarters. The position peaked at $245K in Q3 2023. 188 funds tracked by Wall St. Rank hold RTO as of Q4 2023.

Portside Wealth Group reported no remaining Rentokil position as of Q4 2023 after selling out during the quarter.
Portside Wealth Group sold 6,619 Rentokil shares in Q4 2023, an estimated $245K.
Portside Wealth Group first reported a position in Rentokil in Q2 2023 and held it in 2 quarters.
Portside Wealth Group's Rentokil position peaked at $245K in Q3 2023.
188 funds tracked by Wall St. Rank held Rentokil as of Q4 2023.

Based on Portside Wealth Group's 13F filing for Q4 2023, filed 16 Jan 2024.